{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-045154","form_type":"8-K","ticker":"FHTX","cik":"0001822462","company_name":"Foghorn Therapeutics Inc.","filed_at":"2026-06-24T20:01:11+00:00","discovered_at":"2026-06-24T20:02:00.418071+00:00","generated_at":"2026-06-24T20:02:20.875702+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Foghorn Therapeutics reports 2026 annual meeting voting results; all proposals pass","bullets":["Director nominees elected: Cole (35.1M for, 11.0M against), Gill (46.0M for), Parshall (44.4M for).","Ratification of Deloitte & Touche as auditor for FY2026 approved with 51.7M votes for.","Advisory vote on executive compensation approved with 45.6M for vs 0.5M against.","Stockholders recommended 1-year frequency for future say-on-pay votes (45.6M for one year)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-045154","json":"https://secwatch.observer/filing/0001628280-26-045154.json","markdown":"https://secwatch.observer/filing/0001628280-26-045154.md","text":"https://secwatch.observer/filing/0001628280-26-045154.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822462/000162828026045154/0001628280-26-045154-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822462/000162828026045154/fhtx-20260624.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T20:02:20.875702+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}